Clinical trialNCT02581059TerminatedPhase 2Interventional

Efficacy of Ginseng for Patients on Regorafenib

SponsorWake Forest University Health SciencesEnrollment10Colorectal CancerPalliative MedicineSupportive Care

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a randomized, multi-center phase II study of ginseng in colorectal cancer patients treated with regorafenib to determine if ginseng will reduce fatigue in this patient population and improve adherence to regorafenib. Ninety (90) subjects will be enrolled and randomized using a 2:1 allocation, with 60 subjects enrolled in the regorafenib + ginseng group and 30 enrolled in the regorafenib + no ginseng group.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Rodwige J. Desnoyers, M.D.
Hoosier Cancer Research Network
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Iu Health Central Indiana Cancer Centers
Indianapolis, Indiana, United States
Indiana Univeristy Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Altantic Health System
Morristown, New Jersey, United States
Comprehensive Cancer Center at Wake Forest Baptist
Winston-Salem, North Carolina, United States
Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Regorafenib →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2016
Primary completion: 22 Jun 2018
Completion: 22 Jun 2018
Last update posted: 26 Jun 2024
Registered enrollment: 10
Registry id: NCT02581059

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.